Matrix Capital Management — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Workers' compensation management software company managing employee lifecycle from hire to retirement.
Overland Park, US
Matthew Condon(Executive Officer, Director)inJeff Hogland(Executive Officer, Director)Paul Morris(Executive Officer, Director)in
BoardRobert K Green(Director)Matthew Ferguson(Director)
Co-investorsKCRise FundNewRoad Capital Partners, LLC
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.